Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Current Assets (2016 - 2025)

Historic Current Assets for Coherus Oncology (CHRS) over the last 13 years, with Q3 2025 value amounting to $461.0 million.

  • Coherus Oncology's Current Assets rose 2491.19% to $461.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $461.0 million, marking a year-over-year increase of 2491.19%. This contributed to the annual value of $341.6 million for FY2024, which is 2818.32% down from last year.
  • As of Q3 2025, Coherus Oncology's Current Assets stood at $461.0 million, which was up 2491.19% from $380.2 million recorded in Q2 2025.
  • In the past 5 years, Coherus Oncology's Current Assets ranged from a high of $673.0 million in Q3 2021 and a low of $310.2 million during Q1 2025
  • Moreover, its 5-year median value for Current Assets was $448.3 million (2022), whereas its average is $474.2 million.
  • Per our database at Business Quant, Coherus Oncology's Current Assets surged by 9861.52% in 2024 and then tumbled by 5056.79% in 2025.
  • Quarter analysis of 5 years shows Coherus Oncology's Current Assets stood at $602.3 million in 2021, then crashed by 36.71% to $381.2 million in 2022, then rose by 24.76% to $475.6 million in 2023, then dropped by 28.18% to $341.6 million in 2024, then soared by 34.95% to $461.0 million in 2025.
  • Its last three reported values are $461.0 million in Q3 2025, $380.2 million for Q2 2025, and $310.2 million during Q1 2025.